The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 320.00
Bid: 318.00
Ask: 321.00
Change: -9.00 (-2.74%)
Spread: 3.00 (0.943%)
Open: 325.00
High: 328.00
Low: 317.00
Prev. Close: 329.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

16 Mar 2020 18:05

RNS Number : 3627G
Bank of Cyprus Holdings PLC
16 March 2020
 

 

Announcement

 

 

Nicosia, 16 March 2020

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014.

 

 

Update on Coronavirus (COVID-19)

Following a request by the Cyprus Securities and Exchange Commission to issue an announcement regarding the potential financial impact that a possible outbreak of the COVID-19 in Cyprus may have on the business and operations of Bank of Cyprus Holdings Public Limited Company ("BOC Holdings" and, together with its subsidiaries, the "Group"), the Group would like to note the following.

 

In light of the recent outbreak of COVID-19 in Cyprus and the relevant measures announced by the government of Cyprus on 15 March 2020, the Group confirms that it is taking all appropriate measures, in line with guidelines and recommendations issued by the Ministry of Health, to guarantee service coverage for its customers while protecting the health of both customers and staff.

 

All branches of Bank of Cyprus Public Company Limited (the "Bank") currently remain open. To the extent that the spread of the virus necessitates the closure of any branches, the Bank will inform the public through the press. Information about the operation of the Bank's branches can be found on the Bank's website:www.bankofcyprus.com.cy. Customers of the Bank are encouraged to carry out their daily banking transactions online via the Bank's digital service channels, including the Bank's internet banking platform ("1Bank"), its mobile banking application, the Call Centre and the ATMs.

 

The Group is closely monitoring developments and the effects of the impact of COVID-19 on the global economy. On the basis of currently available information, the Group is not in a position to assess the likelihood and/or magnitude of any future impact of COVID-19 on the Group's operations, as this will mainly depend on the rate and extent of the spread of the virus, its direct and indirect impact on customers and measures taken to support the economy. Any prolonged outbreak of COVID-19, resulting in further weakening of the global bond markets, or further deterioration of the interest rate environment, or any impact on the wider Cypriot economy, is expected to have a negative impact on the Group's financial results for the current year.

 

The Group notes the positive package of measures announced by the European Central Bank, the European Commission and the Cyprus Government which should help to support the European and Cypriot economy, as the impact of the virus becomes more apparent, and provide a degree of capital flexibility for the Group.

 

Update on NPE sale

Against the backdrop of market volatility arising out of the COVID-19 pandemic, the Group continues to work with its advisers towards the sale of a portfolio of NPEs. Due to prevailing market and operational conditions, this process may take longer than originally anticipated. In the context of expected credit losses under IFRS 9, the Bank expects to recognise additional provisions of c.€75 mn on the Group's 4Q2019 financial results, with a negative capital impact of c.45 bps. On completion of an NPE trade, the Group's capital ratios would benefit from a RWA reduction, subject to regulatory approval.

The Group continues to operate with significant surplus liquidity of €3.0 bn as at 30 September 2019. The Group's CET1 ratio and Total capital ratio as at 30 September 2019 stood at 14.9% and 17.9% respectively, both pro forma for the disposal of the investment in CNP and the voluntary staff exit plan that was completed in 4Q2019, well above regulatory requirements.

For further information, please contact Investor Relations at investors@bankofcyprus.com.

 

 

 

[1] Based on the Group's Financial Results for the nine months ended 30 September 2019.

 

 

 

 

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. The Bank of Cyprus Group operates through a total of 108 branches in Cyprus, of which 11 operate as cash offices. Bank of Cyprus also has representative offices in Russia, Ukraine and China. The Bank of Cyprus Group employs 4,134* staff worldwide. At 30 September 2019, the Group's Total Assets amounted to €21.1 bn and Total Equity was €2.5 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

 

\* The Bank of Cyprus Group employed 4,134 staff worldwide as at 30 September 2019. The number of staff has been reduced by c.470 employees following the completion of a voluntary staff exit plan in October 2019.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFLFEDVRIRLII
Date   Source Headline
25th Apr 20247:26 amRNSBOCH - Transactions in Own Shares
25th Apr 20247:00 amRNSIssue of Green Senior Preferred Notes by BOC PCL
24th Apr 20247:00 amRNSBOCH - Transaction in Own Shares
24th Apr 20247:00 amRNSTR1 Notification - Helikon
24th Apr 20247:00 amRNSTR1 Notification -Helikon
23rd Apr 20247:25 amRNSBOCH - Transactions in Own Shares
22nd Apr 20247:27 amRNSBOCH - Transactions in Own Shares
19th Apr 20247:41 amRNSLaunch of share buyback programme
12th Apr 202410:02 amRNSNotice of AGM
5th Apr 20247:20 amRNS2023 Pillar 3 Disclosures
2nd Apr 20241:21 pmRNSTR1 Notification of Holdings - OSOME
2nd Apr 202412:59 pmRNSTR1 Notification of Holdings - OSOME
28th Mar 20242:24 pmRNSBOC Annual Financial Report 2023 Announcement
28th Mar 20241:31 pmRNSBOCH Annual Financial Report 2023 Announcement
28th Mar 20241:30 pmRNSFY2023 Investor Presentation Announcement
28th Mar 20241:30 pmRNSFY2023 Group Financial Results
20th Mar 20247:00 amRNSAnnouncement of Distribution
15th Mar 20249:21 amRNSDate of Announcement of Audited FY2023 FS
19th Feb 20247:01 amRNSDoc re. (Prelim FY2023 Investor Presentation)
19th Feb 20247:00 amRNSPreliminary FY2023 Group Financial Results
6th Feb 20248:41 amRNSDate of announcement of Preliminary FY2023 FR
22nd Dec 20239:09 amRNSRevised Date of AGM
20th Dec 20238:32 amRNSChanges in the composition of the BOD & Committees
13th Dec 20237:00 amRNSEU-wide Transparency Exercise 2023
11th Dec 20232:51 pmRNSChanges in the composition of the BOD
29th Nov 202310:28 amRNSDecision to call AT1 Capital Securities
29th Nov 20238:19 amRNSDate of Annual General Meeting
20th Nov 20239:58 amRNSAppointment of New Director
13th Nov 20237:00 amRNSDoc re. (9M2023 Investor Presentation)
13th Nov 20237:00 amRNS9M2023 Group Financial Results
27th Oct 20237:17 amRNSDate of announcement of 9M2023 FR
24th Oct 202312:41 pmRNSTR1 Notification - Caius
13th Oct 202312:27 pmRNSChanges in the composition of the BODs
27th Sep 20238:28 amRNSDirectorate Change
31st Aug 20237:37 amRNSChanges in the composition of BOD
11th Aug 20239:55 amRNSAppointment of new director
21st Jul 202310:43 amRNSDate of announcement of 1H2023 FR
18th Jul 20234:43 pmRNSIssue of Senior Preferred Notes
3rd Jul 202311:48 amRNSBuyback of Additional Tier 1 Capital Securities
23rd Jun 202312:48 pmRNSComposition of the Boards of Directors
20th Jun 202312:22 pmRNSResults of Additional Tier 1 Tender Cash Offer
19th Jun 202312:34 pmRNSTR1 Notification of Major Holdings - Caius
13th Jun 20233:43 pmRNSRefinancing of AT1 Capital Securities
12th Jun 202311:36 amRNSPDMR Notification of Transaction – Iordanou
12th Jun 20239:40 amRNSLaunch of Cash Tender Offer for AT1 Cap.Securities
12th Jun 20238:39 amRNSPDMR Notification of Transaction – Iordanou
8th Jun 20239:01 amRNSDoc re. (Investor Presentation Update)
8th Jun 20239:00 amRNSAnnouncement for the Investor Update Event
30th May 20237:00 amRNSTR1 Notification of Major Holdings -Eaton Vance
26th May 20235:57 pmRNSResult of AGM-Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.